Psicodinâmica do trabalho na medicina nuclear com o Iodo-131

da Silveira, Leila Cunha; Rodrigues Guilam, Maria Cristina; de Oliveira, Sergio Ricardo
November 2013
Revista Ciência & Saúde Coletiva;nov2013, Vol. 18 Issue 11, p3169
Academic Journal
This paper seeks to demonstrate to what extent alternative forms adopted in the working process of professionals with iodine-131 in nuclear medicine can assist in managing risks of ionizing radiation. The design is based on the main theoretical concepts of the psychodynamics of work in relation to workers' health. In the case study, data were gathered from 15 workers of a public health institution in the city of Rio de Janeiro by means of semi-structured individual interviews and non-systematic direct observation. Bardin's content analysis method was used for the data analysis. When comparing the results obtained with standard prescribed models, it was found that the respondents had changed their approach. They developed individual defense mechanisms, such as denial of risk, and collective defensive strategies, leading them to tackle the greatest danger as a form of defense. The defensive role of ideologies of the profession are manifest. On the contrary, the acquired knowledge derived from prudence proved effective in minimizing the risks of radiation exposure. The authors discuss the limitations of security management that does not consider the workers' subjectivity and inherent knowledge.


Related Articles

  • Reply. Sabri, O. // European Journal of Nuclear Medicine;2001, Vol. 28 Issue 3, p394 

    Replies to a comment made on an article about the treatment of differentiated nonmedullary thyroid carcinoma. Effect of thyroid uptake of a second application of radioiodine; Results of a reduction in thyroid uptake; Difficulty in quantifying how much of the administered radioiodine is absorbed...

  • Radioiodine Treatment of Differentiated Thyroid Carcinoma: The Experience at Seoul National University Hospital. Lee, Ho Young; Chung, June-Key; Lee, Jong Jin; Oh, So Won; Kang, Keon Wook; Park, Do Joon; Cho, Bo Youn; Lee, Myung Chul // Current Medical Imaging Reviews;2010, Vol. 6 Issue 1, p2 

    Radioactive iodine therapy has played an important role in the management of differentiated thyroid cancer (DTC) since specific accumulation of iodide in the thyroid gland was initially reported. The incidence of thyroid cancer is increasing in many countries including Korea. Conventional RIT...

  • Current Safety Practices Relating to I-131 Administration for Diseases of the Thyroid: A Survey of Physicians and Allied Practitioners. Carol Greenlee; Lynn A. Burmeister; Robert S. Butler; Charlotte H. Edinboro; Shannon McIntyre Morrison; Mira Milas The American Thyroid Association Radiation Safety Precautions Survey Task Force // Thyroid;Feb2011, Vol. 21 Issue 2, p151 

    Background:There is little information about the individual safety instructions provided by healthcare professionals to patients receiving radioactive iodine (I-131) therapy for the treatment of benign and malignant thyroid disorders or about whether these instructions are consistent across...

  • Radioiodine therapy dosimetry in benign thyroid disease and differentiated thyroid carcinoma. Salvatori, Massimo; Luster, Markus // European Journal of Nuclear Medicine & Molecular Imaging;Apr2010, Vol. 37 Issue 4, p821 

    The article focuses on the dosimetry for radioiodine treatment of benign thyroid disease and differentiated thyroid carcinoma. It states that the importance that individual patient dosimetry is acquiring in contemporary nuclear medicine therapy can be seen through the radioiodine treatment of...

  • Difficulties in deciding whether to ablate patients with putatively 'low-intermediate-risk' differentiated thyroid carcinoma: do guidelines mainly apply in the centres that produce them? Results of a retrospective, two-centre quality assurance study. Frangos, Savvas; Iakovou, Ioannis; Marlowe, Robert; Eftychiou, Nicolaos; Patsali, Loukia; Vanezi, Anna; Savva, Androulla; Mpalaris, Vassilis; Giannoula, Evanthia // European Journal of Nuclear Medicine & Molecular Imaging;Dec2015, Vol. 42 Issue 13, p2045 

    Purpose: We determined the reasons for radioiodine thyroid remnant ablation, and the procedure's necessity based on postsurgical remnant size, in patients with putatively 'low-intermediate-risk' differentiated thyroid carcinoma (DTC). We identified key clinicopathological, treatment and remnant...

  • Nuclear Medicine Physics.  // Indian Journal of Nuclear Medicine;2015 Supplement, Vol. 30, pS40 

    The article presents abstracts on topics related to nuclear medicine physics including the dosimetric comparison of Y-TheraSphere and -SIRSphere therapy, the correlation of dose and absorbed rate in children and young adults who undergone radioiodine therapy and the contrast of slice imaging.

  • Adverse Reactions to Radioiodine 131I Therapy of Goiter in West African Tertiary Hospital. Onimode, Yetunde A.; Ejeh, John E.; Orunmuyi, Akintunde T. // Molecular Imaging & Radionuclide Therapy;Oct2016, Vol. 25 Issue 3, p128 

    Objective: Radioactive iodine therapy (RAIT) is established as an efficient means of treating toxic goiter (TG) globally. The field of nuclear medicine (NM) still appears novel to many Nigerian clinicians and patients. A culturally embedded dread of radiation may raise ethical and moral concerns...

  • Radioiodine-131 in differentiated thyroid cancer: a retrospective analysis of an uptake-related ablation strategy. Verkooijen, Robbert B.T.; Stokkel, Marcel P.M.; Smit, Jan W.A.; Pauwels, Ernest K.J. // European Journal of Nuclear Medicine & Molecular Imaging;2004, Vol. 31 Issue 4, p499 

    In our hospital, a 24-h radioiodine-131 ([sup 131]I) uptake-related ablation strategy is used in patients with differentiated thyroid cancer to destroy thyroid remnants after primary surgery. In this strategy, low doses of [sup 131]I are used, but data in the literature on its efficacy are...

  • THYROID CANCER RADIOIODINE THERAPY: HEALTH SERVICE PERFORMANCE AND RADIATION SAFETY. Vogiatzi, S.; Liossis, A.; Lamprinakou, M. // Radiation Protection Dosimetry;Jul2015, Vol. 165 Issue 1-4, p434 

    Greek Atomic Energy Commission collected data related to radioiodine I-131 therapy (RAIT) delivery to differentiated thyroid carcinoma patients, for the period 2003-13, corresponding to 100 % of hospitals at national level. Radiation safety and health service performance outcome indicators were...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics